z-logo
open-access-imgOpen Access
Role of long-chain and very-long-chain polyunsaturated fatty acids in macular degenerations and dystrophies
Author(s) -
Aihua Liu,
Yanhua Lin,
Ryan Terry,
Kelly C. Nelson,
Paul S. Bernstein
Publication year - 2011
Publication title -
clinical lipidology
Language(s) - English
Resource type - Journals
eISSN - 1758-4299
pISSN - 1758-4302
DOI - 10.2217/clp.11.41
Subject(s) - macular degeneration , polyunsaturated fatty acid , macular dystrophy , long chain , retinal , biology , genetics , ophthalmology , medicine , biochemistry , chemistry , fatty acid , polymer science
Macular degeneration is a progressive, bilateral eye disorder that damages the macula of the human eye. The most common form of macular degeneration is age-related macular degeneration (AMD), which is the leading cause of irreversible blindness in people older than 50 years in developed countries. Autosomal dominant Stargardt disease-3 (STGD3) is an inherited macular dystrophy that has clinical features similar to dry AMD, but occurs at a much earlier age. It is caused by a mutation in the elongation of very-long-chain fatty acids-like 4 ( ELOVL4 ) gene, which is responsible for encoding the elongase enzyme that converts shorter chain fatty acids into C 28 -C 38 very long-chain polyunsaturated fatty acids (VLCPUFAs, total number of carbons ≥24). Diets rich in long-chain polyunsaturated fatty acids (LCPUFAs) have inverse associations with the progression of AMD and STGD3, and a deficiency in retinal LCPUFAs and VLCPUFAs has been detected in AMD retinas and STGD3 animal models. This article systematically summarizes the roles of LCPUFAs and VLCPUFAs in AMD and STGD3, and discusses future research directions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom